Is the invasion depth in millimeters valid to determine the prognosis of early invasive cervical adenocarcinoma?: A case of recurrent FIGO stage IA1 cervical adenocarcinoma

被引:9
作者
Utsugi, K
Shimizu, Y
Akiyama, F
Hasumi, K
机构
[1] Canc Inst Hosp, Dept Gynecol, Toshima Ku, Tokyo 1708455, Japan
[2] Inst Canc, Dept Pathol, Toshima Ku, Tokyo 1708455, Japan
关键词
cervical adenocarcinoma; early invasion; FIGO Stage IA1; recurrence;
D O I
10.1006/gyno.2001.6214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Recurrence of FIGO stage IA1 cervical adenocarcinoma is extremely rare. We herein report a patient with early invasive cervical adenocarcinoma who developed a recurrence in the vaginal stump. Case. A 52-year-old female complained of contact bleeding, Biopsy of the uterine cervix verified cervical adenocarcinoma, and the patient underwent Okabayashi hysterectomy with pelvic lymphadnectomy and bilateral adnectomy. Histopathologic examination of the uterus revealed an invasive cancer 3 mm in depth. Neither lymph node metastasis nor lymph-vascular space invasion was observed. However, the depth of her normal cervical gland area was 2 mm only, and the cancer invasion involved an area which was deeper than the normal cervical gland area. The vaginal stump recurrence developed 4 years after surgery. Conclusion. The depth of invasion with reference to that of normal cervical glands may become a possible prognostic factor for early invasive cervical adenoarcinoma (C) 2001 Academic Press.
引用
收藏
页码:205 / 207
页数:3
相关论文
共 9 条
[1]  
BURGHARDT E, 1991, CANCER-AM CANCER SOC, V67, P1037, DOI 10.1002/1097-0142(19910215)67:4<1037::AID-CNCR2820670429>3.0.CO
[2]  
2-2
[3]  
CRESMAN WT, 1995, INT J GYNECOL OBSTET, V50, P215
[4]   Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases [J].
Elliott, P ;
Coppleson, M ;
Russell, P ;
Liouros, P ;
Carter, J ;
Macleod, C ;
Jones, M .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (01) :42-52
[5]  
KASPAR HG, 1993, OBSTET GYNECOL, V81, P296
[6]  
Östör AG, 2000, INT J GYNECOL PATHOL, V19, P29
[7]  
TESHIMA S, 1985, CANCER, V56, P167, DOI 10.1002/1097-0142(19850701)56:1<167::AID-CNCR2820560126>3.0.CO
[8]  
2-T
[9]  
VANDENBROEK NR, 1995, GYNECOL ONCOL, V59, P297